Oncolytics Biotech Inc. (Nasdaq: ONCY) reports that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE